- Lilly obesity meds Foundayo and Zepbound to gain CVS coverageEli Lilly’s flagship obesity medications will be included in CVS Caremark formularies, likely boosting sales in the most competitive commercial drug market. The company announced Thursday that it…Endpoints · 1mo ago↗ source
- For wearables, it’s a GLP-1 worldWe have two pieces of wearables-related news for you today, and (maybe unsurprisingly) GLP-1s came up in our conversations with both companies. First, Signos raised $20 million for its approach ...Endpoints · 1mo ago↗ source
- ICON audit finds overstated revenue; Secretome and Psilera raise cash👀 ICON’s audit probe is complete: The investigation found that ICON’s revenue was overstated by $65.3 million in 2023 (about 0.8% of its total revenue that year) and by $92.7 million in 2024 (1.1%…